Solutions 4 Wealth, LTD Outlook Therapeutics, Inc. Put Options Transaction History

Solutions 4 Wealth, LTD

  • $51.1 Billion
  • Q3 2024

Put Options

0 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
No transaction found.

Others Institutions Holding OTLK

# of Institutions
3
Shares Held
31.5K
Call Options Held
0
Put Options Held
0
View Full List

About Outlook Therapeutics, Inc.

OTLK Quotes by TradingView
  • Ticker OTLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 226,144,992
  • Market Cap $1.17B
  • Description
  • Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-relate...
More about OTLK
Track This Portfolio

Track Solutions 4 Wealth, LTD Portfolio

Follow Solutions 4 Wealth, LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Solutions 4 Wealth, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Solutions 4 Wealth, LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email